HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

Abstract
Protein arginine deiminase (PAD) activity is upregulated in a number of human diseases, including rheumatoid arthritis, ulcerative colitis, and cancer. These enzymes, there are five in humans (PADs 1-4 and 6), regulate gene transcription, cellular differentiation, and the innate immune response. Building on our successful generation of F- and Cl-amidine, which irreversibly inhibit all of the PADs, a structure-activity relationship was performed to develop second generation compounds with improved potency and selectivity. Incorporation of a carboxylate ortho to the backbone amide resulted in the identification of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine), as PAD inactivators with improved potency (up to 65-fold) and selectivity (up to 25-fold). Relative to F- and Cl-amidine, the compounds also show enhanced potency in cellulo. As such, these compounds will be versatile chemical probes of PAD function.
AuthorsCorey P Causey, Justin E Jones, Jessica L Slack, Daisuke Kamei, Larry E Jones, Venkataraman Subramanian, Bryan Knuckley, Pedram Ebrahimi, Alexander A Chumanevich, Yuan Luo, Hiroshi Hashimoto, Mamoru Sato, Lorne J Hofseth, Paul R Thompson
JournalJournal of medicinal chemistry (J Med Chem) Vol. 54 Issue 19 Pg. 6919-35 (Oct 13 2011) ISSN: 1520-4804 [Electronic] United States
PMID21882827 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Amidines
  • Antineoplastic Agents
  • N-alpha-(2-carboxyl)benzoyl-N5-(2-chloro-1-iminoethyl)ornithine amide
  • N-alpha-(2-carboxyl)benzoyl-N5-(2-fluoro-1-iminoethyl)ornithine amide
  • Doxorubicin
  • Ornithine
  • Hydrolases
Topics
  • Amidines (chemical synthesis, chemistry, pharmacology)
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Biological Availability
  • Cell Differentiation (drug effects)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Crystallography, X-Ray
  • Doxorubicin (pharmacology)
  • Drug Screening Assays, Antitumor
  • Drug Synergism
  • Humans
  • Hydrolases (antagonists & inhibitors, chemistry)
  • Kinetics
  • Molecular Structure
  • Ornithine (analogs & derivatives, chemical synthesis, chemistry, pharmacology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: